Perbak Capital Partners LLP Bio Rad Laboratories, Inc. Transaction History
Perbak Capital Partners LLP
- $135 Billion
- Q1 2025
A detailed history of Perbak Capital Partners LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Perbak Capital Partners LLP holds 925 shares of BIO stock, worth $228,530. This represents 0.17% of its overall portfolio holdings.
Number of Shares
925
Previous 4,199
77.97%
Holding current value
$228,530
Previous $1.38 Billion
83.67%
% of portfolio
0.17%
Previous 0.74%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$472 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$387 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$383 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$226 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$217 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.09B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...